News

Abbreviated MRI breast cancer screening protocol accurate

Publish date: September 9, 2013

 

AT THE ASCO BREAST CANCER SYMPOSIUM

Dr. Kuhl has been a consultant to Bayer. She reported no other relevant financial disclosures.

*This story was updated 10/16/2013.

sboschert@frontlinemedcom.com

On Twitter @sherryboschert

Pages

Recommended Reading

Long-term CCB therapy linked to higher breast cancer risk
Breast Cancer ICYMI
Bernard Fisher at 95
Breast Cancer ICYMI
Lymph node status predicted 10-year mortality in BRCA1 mutation carriers with small, stage I-III breast cancers
Breast Cancer ICYMI
Long-term amenorrhea risk no higher for premenopausal breast cancer patients with BRCA mutations
Breast Cancer ICYMI
Adjuvant ibandronate adds no benefit in early stage, node-positive breast cancer
Breast Cancer ICYMI
Occult cancer: suspected breast and BRCA gene mutations
Breast Cancer ICYMI
Minimizing cancer’s impact on bone with denosumab: current and future perspectives
Breast Cancer ICYMI
No increase in cardiovascular risk seen after radiation therapy for DCIS
Breast Cancer ICYMI
Most women misestimate their breast cancer risk
Breast Cancer ICYMI
Perioperative MRI fails to reduce recurrence risk in women with ductal carcinoma in situ
Breast Cancer ICYMI